Abstract. FGFR2 is an oncogene amplified in diffuse-type gastric cancer, and WDR11 is a tumor suppressor gene disrupted in glial tumor. WDR11-FGFR2 locus on human chromosome 10q26 is one of cancer-related recombination hot spots. In this study, we investigated recombination and nucleotide substitution around the WDR11-FGFR2 locus during evolution by using bioinformatics. Inter-chromosomal comparison revealed that the human BAG3-FGFR2-TACC2 region was paralogous to the human BAG4-FGFR1-TACC1 region. Inter-specific comparison on the BAG3-FGFR2-TACC2 region revealed that HTPAPL-WDR11-FGFR2 locus containing species-specific insertion or deletion was one of evolutionary recombination hot spots. Between human and mouse, coding-region nucleotide substitution rate and amino-acid substitution rate were significantly lower in the HTPAPL-WDR11-FGFR2 locus than in the surrounding locus (P<0.0001). The HTPAPL-WDR11-FGFR2 locus was more susceptible to recombination than to nucleotide substitution. Detailed comparison of human and mouse genomes could identify evolutionary recombination hot spots overlooked during gross comparison of human and mouse genomes. Because DNA double-strand break is the initial step in various types of recombination including chromosomal translocation, rearrangement, deletion, gene amplification, retroviral integration and retrotransposition, it is reasonable that the HTPAPL-WDR11-FGFR2 locus is the recombination hot spot during evolution as well as during carcinogenesis. Therefore, comparative genomics might be applicable to identification of recombination hot spots and genes related to cancer.
Introduction
Fibroblast growth factors (FGFs) play key roles in morphogenesis, angiogenesis, tissue remodeling and carcinogenesis (1) (2) (3) . FGF transduces signals through FGF receptors with tyrosine kinase domain (FGFR1-FGFR4). Activation of FGFRs due to dimerization triggered by FGF binding leads to the elevation of intracellular Ca 2+ levels, the activation of phospholipase C (PLC), and the activation of distinct signaling pathways such as the mitogen-activated protein kinase (MAPK) pathway and the PI3-kinase/AKT pathway (4, 5) .
FGFR2 gene on human chromosome 10q26 is an oncogene amplified in diffuse-type gastric cancer (6) (7) (8) and breast cancer (9) . We have recently reported that FGFR2 gene is closely linked to WDR11 tumor suppressor gene (10) in the tail-to-tail manner with an interval of ca. 570 kb (11) . Exon 21 and the 3'-flanking region of the FGFR2 gene is deleted due to breakage-fusion-bridge process during FGFR2 gene amplification in KATO-III and OCUM-2M cells to exclude WDR11 gene from the FGFR2 amplicon (11) . The WDR11-FGFR2 locus is one of cancer-related recombination hot spots.
In this study, we investigated recombination and nucleotide substitution rates around the WDR11-FGFR2 locus during evolution by using bioinformatics. Comparative genomic analyses revealed that the HTPAPL-WDR11-FGFR2 locus was one of recombination hot spots during evolution, and also that nucleotide and amino-acid substitution rates between human and mouse were significantly lower in the region corresponding to the HTPAPL-WDR11-FGFR2 locus. This is the first report indicating that the HTPAPL-WDR11-FGFR2 locus is the recombination hot spot not only during carcinogenesis but also during evolution.
Materials and methods
Phylogenetic analysis. Phylogenetic analysis of human FGFR1, FGFR2, FGFR3, FGFR4 and mouse orthologous proteins was performed with the CLUSTALW program (http://www.ddbj.nig.ac.jp) as described previously (12, 13) .
Inter-chromosomal comparative genomics. Human reference genomic contigs corresponding to FGFR2-WDR11 locus as well as FGFR1 locus were identified by using Tblastn program (http://www.ncbi.nlm.nih.gov) as described previously (14, 15) . Genes around FGFR2 and FGFR1 loci were listed up based on the description of human reference genomic contigs. Presence and localization of paralogs corresponding to genes around the FGFR2 and FGFR1 loci were investigated by using the Blastn and Tblastn programs.
Recombination cluster around FGFR2-WDR11-HTPAPL locus on human chromosome 10q26
Inter-specific comparative genomics. Mouse WGS supercontig corresponding to the Fgfr2-Wdr11 locus was identified by using the Tblastn program as described previously (16) . After listing-up of genes around the mouse Fgfr2 locus, presence and localization of orthologs corresponding to genes around the human FGFR2 locus and the mouse Fgfr2 locus were investigated by using the Blastn and Tblastn programs. Nucleotide and deduced amino-acid sequences of human and mouse orthologs were aligned by using the Genetyx-Mac vesion 10.1 program (Software Development) to determine nucleotide and amino-acid substitution rates between human and mouse orthologs.
Statistical analyses. Significance of nucleotide and aminoacid substitution rates between human and mouse orthologs were statistically analyzed with the ¯2 test by using the StatView version 5.0 program (SAS Institute). (Fig. 1B) . In addition, mouse Sac2 and Flj13081/BC025641 genes were identified between mouse Bag3 and P125 genes by using the BLAST programs (Fig. 2) .
Results

Phylogenetic
Inter-specific comparison between the human BAG3-FGFR2-TACC2 region and the mouse Bag3-Fgfr2-Tacc2 region revealed that the BAG3-SAC2-FLJ13081-P125 subregion and the ATE1-FLJ20003-TACC2 sub-region were evolutionarily conserved without species-specific insertion or deletion of additional genes. On the other hand, RPL21, RPL19L and RPS15AL genes were located within the human HTPAPL-WDR11-FGFR2 sub-region, while Arhnl, 1700102J08Rik and BC027246 genes were located within the mouse Htpapl-Wdr11-Fgfr2 sub-region. Because human RPL21, RPL19L, RPS15AL genes and mouse Arhnl, 1700102J08Rik and BC027246 genes were not related to each other, we concluded that the HTPAPL-WDR11-FGFR2 locus containing species-specific insertion or deletion was one of evolutionary recombination hot spots (Fig. 2) .
Cancer-related breakpoints around the WDR11-FGFR2 locus have been reported in a glial tumor with t(10;19) translocation and gastric cancer with FGFR2 gene amplification (10, 11) . These results clearly indicate that the HTPAPL-WDR11-FGFR2 locus was the recombination hot spot during carcinogenesis as well as during evolution (Fig. 2) .
Nucleotide and amino-acid substitution rates around the HTPAPL-WDR11-FGFR2 locus.
We next investigated nucleotide and amino-acid substitution rates between the human BAG3-FGFR2-TACC2 region and the mouse Bag3-Fgfr2-Tacc2 region. SAC2 and P125 genes were excluded from calculation of nucleotide and amino-acid substitution rates due to unavailability of complete coding sequences of mouse orthologs. Because introns as well as non-coding region within exons are not well conserved during evolution, nucleotide substitution rate was calculated by comparing the coding region of representative splicing variant derived from each gene. HTPAPL and FGFR2 genes showed relatively lower nucleotide substitution rates between human and mouse. FLJ13081, HTPAPL, WDR11 and FGFR2 proteins showed relatively lower amino-acid substitution rates between human and mouse (Fig. 3A) .
HTPAPL, WDR11 and FGFR2 genes were classified as genes within the recombination cluster, while BAG3, FLJ13081, ATE1, FLJ20003 and TACC2 genes were classified as genes in the surrounding region. Coding-region nucleotide substitution rate within the recombination cluster (10.8%) was significantly lower than that in the surrounding region (15.0%) (P<0.0001). Amino-acid substitution rate within the recombination cluster (4.4%) was also significantly lower than that in the surrounding region (13.1%) (P<0.0001). Therefore, nucleotide and amino-acid substitution rates were significantly lower within the recombination cluster corresponding to the HTPAPL-WDR11-FGFR2 locus (Fig. 3B) .
Discussion
The WDR11-FGFR2 locus is one of cancer-related recombination hot spots, because breakpoints within the WDR11-FGFR2 locus have been reported in a glial tumor with the t(10;19) translocation and gastric cancer with the FGFR2 gene amplification (10, 11) . In this study, recombination around the WDR11-FGFR2 locus during evolution was investigated by using comparative genomic approach.
Because FGFR2 was most homologous to FGFR1 (Fig. 1A) , the region around the FGFR2 gene on human chromosome 10q26 was compared with the region around FGFR1 gene on human chromosome 8p11 (Fig. 1B) . Inter-chromosomal comparative genomic analysis revealed that the human BAG3-FGFR2-TACC2 region was paralogous to the human BAG4-FGFR1-TACC1 region. These paralogous regions around the FGFR2 and FGFR1 loci might be generated due to genomic duplication during evolution.
The human BAG3-FGFR2-TACC2 region on human chromosome 10q25.2-q26 was next compared with the syntenic region on mouse chromosome 7 (Fig. 2) . Inter-specific comparative genomic analysis revealed that the HTPAPL-WDR11-FGFR2 locus containing species-specific insertion or deletion of several genes was the recombination hot spot during evolution (Fig. 2) .
HTPAPL, WDR11 and FGFR2 genes in the recombination cluster showed relatively lower coding-region nucleotide substitution rate and amino-acid substitution rate than other genes in the surrounding region (Fig. 3A) . Coding-region nucleotide substitution rate as well as amino-acid substitution rate were significantly lower in the HTPAPL-WDR11-FGFR2 locus than in the surrounding region (Fig. 3B) . Thus, the HTPAPL-WDR11-FGFR2 locus was more susceptible to recombination than to nucleotide substitution.
Starting from a common ancestral genome approximately 75 Myr, human and mouse genomes have each been shuffled by chromosomal rearrangements. A total of 342 conserved syntenic segments have been identified based on gross comparison of human and mouse genomes (17) . Because the HTPAPL-WDR11-FGFR2 locus was located within the syntenic segment rather than around the syntenic junction (Fig. 2) , detailed comparison between human and mouse genomes could identify evolutionary recombination hot spots overlooked during gross comparison of human and mouse genomes.
Oncogenes and tumor suppressor genes are clustered around recombination hot spots or fragile sites in the genome, because DNA double-strand break is the initial step in various types of recombination including chromosomal translocation, rearrangement, deletion, gene amplification, retroviral integration and retrotransposition (18) (19) (20) (21) (22) (23) (24) . Therefore, it is reasonable that the HTPAPL-WDR11-FGFR2 locus is the recombination hot spot during carcinogenesis as well as during evolution. Comparative genomics might be applicable to identification of recombination hot spots and genes related to cancer.
